OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 859-859
Open Access | Times Cited: 12
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 859-859
Open Access | Times Cited: 12
Showing 12 citing articles:
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 18
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 18
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease
Jakub RochoĊ, Piotr Kalinowski, Ksenia Szymanek-Majchrzak, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 23, pp. 2964-2980
Open Access | Times Cited: 7
Jakub RochoĊ, Piotr Kalinowski, Ksenia Szymanek-Majchrzak, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 23, pp. 2964-2980
Open Access | Times Cited: 7
Gut microbiome and metabolome characteristics of patients with cholesterol gallstones suggest the preventive potential of prebiotics
Ye Liu, Hexin Li, Tieying Sun, et al.
iMeta (2025)
Open Access
Ye Liu, Hexin Li, Tieying Sun, et al.
iMeta (2025)
Open Access
A critical review of microbiome-derived metabolic functions and translational research in liver diseases
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis
Aysun Yakut
World Journal of Hepatology (2025) Vol. 17, Iss. 3
Closed Access
Aysun Yakut
World Journal of Hepatology (2025) Vol. 17, Iss. 3
Closed Access
Low Short-Chain-Fatty-Acid-Producing Activity of the Gut Microbiota Is Associated with Hypercholesterolemia and Liver Fibrosis in Patients with Metabolic-Associated (Non-Alcoholic) Fatty Liver Disease
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Gastrointestinal Disorders (2023) Vol. 5, Iss. 4, pp. 464-473
Open Access | Times Cited: 7
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Gastrointestinal Disorders (2023) Vol. 5, Iss. 4, pp. 464-473
Open Access | Times Cited: 7
Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients
Yohei Midori, Takuto Nosaka, Katsushi Hiramatsu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Yohei Midori, Takuto Nosaka, Katsushi Hiramatsu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota
Siyuan Sun, Guangheng Zhang, Shimeng Lv, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Siyuan Sun, Guangheng Zhang, Shimeng Lv, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Does Timing of Ileal Pouch-Anal Anastomosis Matter in Patients with Primary Sclerosing Cholangitis and Orthotopic Liver Transplantation? A Systematic Review and Meta-analysis
Saqr Alsakarneh, Mohamed Ahmed, Fouad Jaber, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 3
Open Access
Saqr Alsakarneh, Mohamed Ahmed, Fouad Jaber, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 3
Open Access
Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2024) Vol. 34, Iss. 4, pp. 64-74
Open Access
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2024) Vol. 34, Iss. 4, pp. 64-74
Open Access
Tryptophan Metabolites in the Progression of Liver Diseases
M. S. Reshetova, Pavel A. Markin, Svetlana A. Appolonova, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1449-1449
Open Access
M. S. Reshetova, Pavel A. Markin, Svetlana A. Appolonova, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1449-1449
Open Access
Angelica sinensis polysaccharide could alleviate the gastrointestinal damage in alcoholic fatty liver disease mice: Regulation of alcohol metabolism and enhancement of short-chain fatty acids utilization
Zihao He, Shuaiqing Deng, Zhijing Wu, et al.
Journal of Ethnopharmacology (2024), pp. 119117-119117
Closed Access
Zihao He, Shuaiqing Deng, Zhijing Wu, et al.
Journal of Ethnopharmacology (2024), pp. 119117-119117
Closed Access
